Established in 2004, this premier specialty pharmacy has built a 20-year reputation as a dominant player in the market. Operating out of a sprawling, high-traffic 10,000 sq. ft. facility, the business is a highly oiled machine, consistently dispensing an average of 700 prescriptions every single day.

This is being offered as an exclusive "Two-Package Deal," combining a massive retail/specialty footprint with highly lucrative pharmaceutical contracts and licensing.

Unmatched Revenue Drivers:
What sets this pharmacy apart from standard retail operations are its specialized contracts and licenses, which act as a massive moat against the competition:

The 340B Advantage: The pharmacy holds a highly sought-after 340B contract, allowing for significantly widened profit margins on specialty drugs.

HIV Collaborative Agreement: A newly executed collaborative agreement with a local 340B doctor allows the pharmacy to directly test for and prescribe HIV medications. This is one of the highest-margin sectors in the specialty pharmacy space and offers massive immediate upside for the new owner.

Wholesale License Included: The business holds an active wholesale license, providing an entirely separate, highly profitable B2B revenue channel.

Clean PBM Contracts: The business holds active, clean contracts with all major insurance carriers and PBMs, ensuring a seamless transition of cash flow.

Strategic Synergy & Expansion ("The Poppies Merger"):
Included in the strategic roadmap is a rare opportunity to absorb/merge with a neighboring, complementary business ("Poppies"). Executing this consolidation will immediately slash overhead costs—including rent, payroll, and dual licensing fees—driving the bottom-line net profit even higher.

Operations & Staffing:
The current operation is highly efficient and designed to handle volume. The majority owner is retiring after a highly successful two-decade run, and the minority owner is transitioning out to pursue other ventures. This creates the perfect clean-slate opportunity for an experienced operator, expanding pharmacy group, or healthcare investor to take 100% control of a thriving enterprise.

Key Investment Highlights at a Glance:

Location: Prime Real Estate (10,000 Sq. Ft. Facility)

Volume: 700 Rx / Day consistently

Coveted Contracts: Active 340B Contract & Wholesale License

Growth Catalyst: New HIV testing/prescribing collaborative agreement

History: 20 years of goodwill and an established, loyal patient base

Next Steps:
High-volume 340B specialty pharmacies with wholesale licenses in Florida rarely hit the public market. This will move quickly. Serious buyers must sign an NDA and provide proof of funds to receive the full Confidential Information Memorandum (CIM) and financials.

Contact us today to secure your position!